IMELDA MO22223

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMELDA MO22223, covering 2018-04-13 to 2018-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Retrospective Data Collection: Post Study Treatment Anticancer Therapy From IMELDA MO22223